1955 Capital logo

1955 Capital

1955.capital

VCMatch tracks 1955 Capital as an investor focused on Climate/Cleantech, Mobility/Transportation, and Medtech companies and Global, United States, and Asia markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Geography

global, United States, and Asia

Investment Thesis

1955 Capital pursues a thesis-driven, mission-oriented approach: invest in “advanced technologies with the potential to solve these pressing global problems” (energy & environment, food, manufacturing, health & education) and focus on survival-driven needs where “breakthrough technology is the answer.” They prioritize finding opportunities “before others do,” targeting uninvested or underappreciated categories with asymmetric risk-return, then using domain expertise and active operational support to commercialize technology and build high-growth, world-positive companies.

Is 1955 Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

Investment Focus

Who should take a closer look

1955 Capital is most relevant for founders raising venture-backed rounds in Climate/Cleantech, Mobility/Transportation, Medtech, and Biotech, especially across global, United States, and Asia.

Focus statement

1955 targets breakthrough deep-technology companies in energy & environment, food safety & supply, sustainable manufacturing, and health & education — sectors that can "address the world’s greatest challenges" and deliver both high impact and high returns.

Value Add

  • Founder-led track record and domain credibility: Andrew Chung has "rare experience and success investing in sustainability and health technology" and participated in early investments that created over $30 billion of market value.
  • Thesis-driven, experience-based diligence: they "Craft investment thesis, criteria & DD based on prior experiences" to find areas of "comparative advantage" and "arbitrage opportunities that others miss."
  • Global and cross-border capabilities, especially U.S.-Asia collaboration (Andrew led Asia activities and speaks Mandarin/Cantonese), enabling international commercialization and partnerships.
  • Hands-on, selective operational support: they "Commit to assist where needed" but explicitly avoid overinvesting so they can provide meaningful CEO support.
  • Performance orientation with mission alignment: positioning to "build a high-return model for world-positive investing" and citing "top-quartile performance since inception."

Stage And Sector Fit

Portfolio Highlights

Nature’s Fynd

Alternative Proteins

Noah Medical

Surgical Robotics

Ampaire

Electric Aviation

Gridtential

Energy Storage

Crop Enhancement

Agriculture

Ambri

Energy Storage

BioConsortia

Agriculture

Cogenra

Solar

+ 31 more companies in their portfolio